
Homology Medicines (FIXX) Enterprise Value
Price: $0.93
Market Cap: $3.02M
Avg Volume: 29.54K
Market Cap: $3.02M
Avg Volume: 29.54K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Homology Medicines's latest quarterly financial reports:
- The enterprise value (EV) is -105.39M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 3.52M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $0.9347, with 995.28K shares outstanding.
- The company has 115.51M in cash and cash equivalents and 9.19M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$-105.39M
Market Cap
$930.29K
Total Debt
$9.19M
Cash and Equivalents
$115.51M
Historical Enterprise Value
Homology Medicines Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-03-31.
Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
---|---|---|---|---|---|---|---|
March 31, 2024 | $-105.39M | 206.18% | $0.9347 | 995.28K | $930.29K | $115.51M | $9.19M |
December 31, 2023 | $-34.42M | -674.10% | $10.94 | 322.32K | $3.53M | $39.27M | $1.32M |
September 30, 2023 | $6.00M | -113.96% | $21.06 | 321.41K | $6.77M | $29.11M | $28.34M |
June 30, 2023 | $-42.96M | 874.50% | $15.93 | 321.08K | $5.11M | $76.80M | $28.72M |
March 31, 2023 | $-4.41M | -261.24% | $18.54 | 320.65K | $5.94M | $39.45M | $29.10M |
December 31, 2022 | $2.73M | -166.17% | $22.68 | 319.35K | $7.24M | $33.99M | $29.48M |
September 30, 2022 | $-4.13M | -97.07% | $28.98 | 317.57K | $9.20M | $43.16M | $29.83M |
June 30, 2022 | $-140.95M | -31.82% | $35.46 | 316.87K | $11.24M | $176.19M | $24.00M |
March 31, 2022 | $-206.73M | 224.58% | $54.72 | 318.22K | $17.41M | $248.13M | $23.98M |
December 31, 2021 | $-63.69M | 69.04% | $65.52 | 316.78K | $20.76M | $108.38M | $23.93M |
September 30, 2021 | $-37.68M | -38.29% | $141.66 | 314.90K | $44.61M | $95.83M | $13.54M |
June 30, 2021 | $-61.06M | 44.69% | $130.86 | 313.79K | $41.06M | $116.31M | $14.19M |
March 31, 2021 | $-42.20M | -72.04% | $169.38 | 279.80K | $47.39M | $104.42M | $14.82M |
December 31, 2020 | $-150.93M | 32.89% | $203.22 | 251.26K | $51.06M | $217.43M | $15.44M |
September 30, 2020 | $-113.57M | 37.89% | $192.6 | 251.26K | $48.39M | $178.00M | $16.04M |
June 30, 2020 | $-82.36M | 46.93% | $273.42 | 251.16K | $68.67M | $167.64M | $16.60M |
March 31, 2020 | $-56.06M | -250.59% | $279.72 | 250.84K | $70.16M | $143.37M | $17.15M |
December 31, 2019 | $37.22M | 1850.38% | $372.6 | 244.22K | $91.00M | $53.77M | $- |
September 30, 2019 | $1.91M | -105.48% | $325.8 | 243.91K | $79.47M | $77.56M | $- |
June 30, 2019 | $-34.84M | -151.16% | $337.32 | 239.31K | $80.72M | $115.57M | $- |
March 31, 2019 | $68.10M | 55.66% | $524.52 | 207.69K | $108.94M | $40.84M | $- |
December 31, 2018 | $43.75M | -6.49% | $402.48 | 203.66K | $81.97M | $38.22M | $- |
September 30, 2018 | $46.78M | -336.70% | $399.96 | 207.07K | $82.82M | $36.04M | $- |
June 30, 2018 | $-19.76M | -152.09% | $367.2 | 204.78K | $75.20M | $94.96M | $- |
March 31, 2018 | $37.94M | -325.00% | $336.6 | 250.02K | $84.16M | $46.21M | $- |
December 31, 2017 | $-16.86M | -148.58% | $335.88 | 103.35K | $34.71M | $51.57M | $- |
September 30, 2017 | $34.71M | 0.00% | $335.88 | 103.35K | $34.71M | $- | $- |
June 30, 2017 | $34.71M | 0.00% | $335.88 | 103.35K | $34.71M | $- | $- |
March 31, 2017 | $34.71M | - | $335.88 | 103.35K | $34.71M | $- | $- |
Related Metrics
Explore detailed financial metrics and analysis for FIXX.